Hoofddorp, the Netherlands, 30 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the filing of the appeal to the decision of the SIX to delist the company.
Press releases/News
IGEA to update on SIX decision
Hoofddorp, the Netherlands, 4 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the intention to appeal the decision of the SIX to delist the company.
IGEA discloses its Annual Report 2022
Hoofddorp, the Netherlands, 30 July 2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its Annual Report 2022.
IGEA to apply for a further extension of its disclosure obligations
Hoofddorp, the Netherlands, 31 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the
submission of a further exemption application to the SIX.
IGEA to update on strategic refocusing decisions.
Hoofddorp, the Netherlands, 30 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced a refocusing on its industrial process segment.
IGEA to update on unaudited key figures and ongoing matters
Hoofddorp, the Netherlands, 15 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of unaudited key figures (as anticipated on 30 April 2023) and certain other ongoing matters as follow:
IGEA to get SIX approval to Annual 2022 Report disclosure
Hoofddorp, the Netherlands, 30 April 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2022 Annual Report.
IGEA appoints new Chief Financial Officer
Hoofddorp, the Netherlands, 08 December 2022. IGEA Pharma N.V. (SIX: IGPH) today appointed Diego Fiorentini as new CFO of IGEA Pharma, filling a void that was ad interim covered by the previous CEO.
IGEA announces annual General Meeting Resolutions
Hoofddorp, the Netherlands, 06 December 2022. IGEA Pharma N.V. (SIX: IGPH) today announced that the Annual General Meeting approved all the agenda resolutions. The minutes of the meeting are available at igeapharma.nl/category/information-for-shareholders
IGEA DISCLOSES ITS HALF-2022 FINANCIAL REPORT
Hoofddorp, the Netherlands, 30 October 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of its Half-2022 Financial Report.